Glaucoma News

 
 
  • Topical Prostaglandin Use May Have Negative Impact on Ptosis Repair Topical use of prostaglandin analogues (PGAs) appears to be associated with a poorer outcome following surgery for ptosis (blepharoptosis) repair, according to a retrospective review.
  • Alert EMA Panel Backs Netarsudil for Elevated Intraocular Pressure An EMA advisory panel recommended marketing authorization for netarsudil ophthalmic solution 0.02% for the treatment of adults with glaucoma or ocular hypertension.
  • Statins May Cut Postconcussion Dementia Risk Concussion in older adults is tied to a dramatically increased risk for dementia, but new research suggests statins may mitigate this risk.
  • Alert FDA OKs Rocklatan, a New Once-Daily Eye Drop for Glaucoma The netarsudil and latanoprost ophthalmic solution (Rocklatan) reduces elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
  • Conditions Treated With Cannabis Often Lack Good Evidence Most qualifying conditions have substantial or conclusive evidence behind them, but for many conditions, the evidence doesn't support the number of patients receiving a physician's approval.
  • Take Diabetes Into Consideration When Assessing for Glaucoma Diabetes and hyperglycemia are associated with thicker central corneal thickness, a relationship that could lead to overestimation of intraocular pressure, researchers warn ophthalmologists.
  • AAP Updates Screening Policy for ROP A policy statement from the American Academy of Pediatrics provides updated guidelines for screening and treating retinopathy of prematurity (ROP).
  • Alert FDA Updates Advice on Withdrawn CyPass Glaucoma Stent The FDA is now advising providers to periodically evaluate patients' implanted stents for endothelial cell loss and determine if additional action is needed, including removal of the device.
  • Alert FDA Warns Against Using Raindrop Near Vision Inlay The FDA today issued an alert about an increased risk for corneal haze in patients with the device after 75% of patients in a postapproval study developed haze.
  • AAO 2018Drug Pipeline for Macular Degeneration in Focus at AAO Updates from phase 3 trials of VEGF inhibitors for neovascular age-related macular degeneration, and a novel genetic treatment, will be highlighted at the American Academy of Ophthalmology meeting.
  • Alert FDA Clears New Form of Latanoprost (Xelpros) for Glaucoma Xelpros is the first and only form of latanoprost that is not formulated with benzalkonium chloride, a preservative commonly used in topical ocular preparations.
  • Alert Alcon Pulls CyPass Glaucoma Micro-Stent Off the Global Market The company cites 5-year safety data that show statistically significant endothelial cell loss in patients who received the CyPass stent at the time of glaucoma surgery.
  • AI Speeds Diabetic Retinopathy Diagnosis Without Specialist The first-of-its-kind solution, fast-tracked by the FDA, can be used to detect the disease in primary care and retail clinics without requiring a physician, shows a prospective study.
  • Staying Fit Might Cut Glaucoma Risk Meeting physical activity guidelines and being physically fit may reduce the risk of developing glaucoma by 40 percent to 50 percent, recent research suggests.
  • Alert FDA Clears Hydrus Microstent for Glaucoma The Hydrus microstent used in conjunction with cataract surgery achieves significant and sustained lowering of intraocular pressure in patients with primary open-angle glaucoma.
  • Three Eye Conditions Linked to Higher Alzheimer's Risk More insight into the eye as a 'window into the brain' comes from a study linking glaucoma, age-related macular degeneration, and diabetic retinopathy to a higher risk for Alzheimer's disease.
  • Retinal Thinning Tied to Cognitive Decline In the largest study of its kind to date, investigators found an association between retinal nerve fiber thinning and poorer cognitive performance in healthy individuals.
  • Older Americans Taking Too Many Unneeded Drugs Researchers estimate that 25 percent of people ages 65 to 69 take at least five prescription drugs to treat chronic conditions. But some doctors are trying to teach others about “deprescribing” or systematically discontinuing medicines that are inappropriate, duplicative or unnecessary.
  • Artificial Intelligence Eyed as Diabetic Retinopathy Screen A "deep learning system" can be taught to determine whether or not diabetic retinopathy is present across different ethnicities in a variety of settings.
  • AAOChoose DMEK Over DSEK After Glaucoma Surgery Descemet membrane endothelial keratoplasty provides better outcomes than Descemet-stripping in patients requiring cornea transplant who have already had glaucoma surgery.